Tyra Biosciences announced positive initial Phase 2 results for oral dabogratinib in FGFR3-altered low-grade intermediate-risk non-muscle invasive bladder cancer, showing high response rates and favorable safety. The company completed a $400 million financing round, boosting its cash reserves to $700.5 million, which is expected to fund operations through 2030. Tyra plans to advance dabogratinib through late-stage trials, including a Phase 3 study in 2027, aiming to establish it as a transformative oral therapy for FGFR3-driven diseases. Additional Phase 2 results for related indications are also anticipated in 2027.
Tyra Biosciences reported a $700.5 million cash reserve after a $400 million financing round, as of Nov 10, 2026 19:42 WIB. For readers following the Health sector, here is Pluang's market snapshot: out of 150 priced US health stocks, 83 rose and 55 fell today. Notable movers include HRTX at USD 0.38 (+3.02%, 39 days typical hold time, 58% Sell / 42% Buy), NUWE at USD 4.83 (-2.23%, 32 days hold, 83% Sell / 17% Buy), and INO at USD 1.48 (-1.99%, 41 days hold, 52% Sell / 48% Buy).
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
Viasat has been awarded a $450 million IDIQ contract by the U.S. Space Force to support the design, development, and sustainment of the Space Data Network Backbone (SDN-B) mission operations center. This network aims to provide resilient, high-capaci...
